Engineered “natural killer” cells could help fight cancer
A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.
A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.
The findings may offer a new way to help heal tissue damage from radiation or chemotherapy treatment.
Chemotherapy-induced injury of organ tissue causes inflammation that awakens dormant cancer cells, which may cause new tumors to form.
Outfitted with antibodies that guide them to the tumor site, the new nanoparticles could reduce the side effects of treatment.
Researchers developed a tool to recreate cells’ family trees. Comparing cells’ lineages and locations within a tumor provided insights into factors shaping tumor growth.
CellLENS reveals hidden patterns in cell behavior within tissues, offering deeper insights into cell heterogeneity — vital for advancing cancer immunotherapy.
Electrodes coated with DNA could enable inexpensive tests with a long shelf-life, which could detect many diseases and be deployed in the doctor’s office or at home.
Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.
The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.
Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.
Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.
Scaling up nanoparticle production could help scientists test new cancer treatments.
Graduate student and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.
When scientists stimulated cells to produce a protein that helps “water bears” survive extreme environments, the tissue showed much less DNA damage after radiation treatment.
Stefani Spranger is working to discover why some cancers don’t respond to immunotherapy, in hopes of making them more vulnerable to it.